Institutional investors purchased a net $37.1 thousand shares of ICCC during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 15.54% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEALTHINVEST PARTNERS AB Bought 13.8 Thousand shares of ImmuCell Corp